Investigational Site Number :3920007

Sakai-shi, Osaka 593-8324

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Cold Urticaria

Studies at this site

• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS) — Completed